share_log

T2 Biosystems | RW: Registration Withdrawal Request

T2 Biosystems | RW: Registration Withdrawal Request

T2 Biosystems | RW：注册提款请求
美股sec公告 ·  05/14 17:00
Moomoo AI 已提取核心信息
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
医疗诊断公司T2 Biosystems, Inc. 已正式要求撤回其最初于2024年4月22日向美国证券交易委员会提交的S-1表格注册声明。该公司决定不继续进行注册声明中设想的发行。T2 Biosystems证实，没有根据注册声明出售任何证券。根据2024年5月14日的来文，撤回请求立即生效。该公司的法律顾问迈克尔·吉布斯和瑞生律师事务所的代表正在处理撤回程序。
医疗诊断公司T2 Biosystems, Inc. 已正式要求撤回其最初于2024年4月22日向美国证券交易委员会提交的S-1表格注册声明。该公司决定不继续进行注册声明中设想的发行。T2 Biosystems证实，没有根据注册声明出售任何证券。根据2024年5月14日的来文，撤回请求立即生效。该公司的法律顾问迈克尔·吉布斯和瑞生律师事务所的代表正在处理撤回程序。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息